Fractional Radiofrequency and Oral Isotretinoin—A Prospective Randomized Controlled Split‐Face Trial Comparing Concurrent Versus Delayed Fractional Radiofrequency Treatment for Acne Scars
Lasers in Surgery and Medicine · 2024
DOI: 10.1002/lsm.23811 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Elisa S Gallo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Isotretinoin, Dermatologic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Therapeutic dogma has been to treat acne scars no less than 6 months after isotretinoin (ITN) cessation.
Objective
To evaluate the safety and efficacy of fractional radiofrequency (FRF) in patients treated concurrently with ITN.
Methods
We conducted a prospective randomized control 3‐arm comparative trial to evaluate the treatment of acne scars. Patients received one of three treatment options: (A) ITN and FRF concurrent treatment, (B) ITN monotherapy, and (C) FRF 6 months post‐ITN treatment. Patients in the FRF cohorts received three monthly sessions. Patients were followed for adverse effects up to 6–9 months post‐FRF treatment. Final cosmesis was scored by three independent dermatologists using two scales: the Echelle d'Evaluation Clinique des Cicatrices d'Acne (ECCA) and an internal 5‐point investigator's scale, indicating the percentage of improvement. Subjective analyses by patients were also assessed.
Results
Objective and subjective analyses revealed improvement in the ITN‐FRF cohort, which was superior to the delayed FRF cohort and the ITN monotherapy cohort. Specifically, the concurrently treated cohort (ITN‐FRF) had a significant reduction in acne scar volume from baseline mean (151.1 ± 44.7 to 97.0 ± 31.2, p < 0.005), outperforming both the delayed FRF and monotherapy ITN treatment cohorts, respectively (155.4 ± 37.8 to 122.0 ± 46.2, 144.6 ± 82.8 to 132.4 ± 62.7). Additionally, the concurrently treated cohort demonstrated improved ECCA scores (36.8 ± 15.5), significantly better than the ITN monotherapy cohort (101.5 ± 20.1, p < 0.01).
Limitations
Limited patient sample size: 38 patients completed the study; mostly Fitzpatrick Type II–III skin; photographic assessments utilized.
Conclusion
Per our prospective trial, concurrent treatment of ITN‐FRF is superior to delayed FRF treatment 6 months post‐ITN cessation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Elisa S Gallo
Zitieren
APA
Gallo, E. S., Katz, U., & Artzi, O. (2024). Fractional Radiofrequency and Oral Isotretinoin—A Prospective Randomized Controlled Split‐Face Trial Comparing Concurrent Versus Delayed Fractional Radiofrequency Treatment for Acne Scars. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23811
Vancouver
Gallo ES, Katz U, Artzi O. Fractional Radiofrequency and Oral Isotretinoin—A Prospective Randomized Controlled Split‐Face Trial Comparing Concurrent Versus Delayed Fractional Radiofrequency Treatment for Acne Scars. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23811
BibTeX
@article{Gallo2024,
author = {Gallo, Elisa S and Katz, Uriel and Artzi, Ofir},
title = {Fractional Radiofrequency and Oral Isotretinoin—A Prospective Randomized Controlled Split‐Face Trial Comparing Concurrent Versus Delayed Fractional Radiofrequency Treatment for Acne Scars},
journal = {Lasers in Surgery and Medicine},
year = {2024},
doi = {10.1002/lsm.23811}
}
EUVIMED